Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Is the Nerve Growth Factor (NGF) a Useful Biomarker in Neurogenic Bladder Dysfunction After Spinal Cord Injury?

NCT02138149 is registered in ClinicalTrials.gov with Swiss Paraplegic Research, Nottwil as lead sponsor.

NCT NCT02138149
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02138149 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Is the Nerve Growth Factor (NGF) a Useful Biomarker in Neurogenic Bladder Dysfunction After Spinal Cord Injury?
Lead sponsor
Swiss Paraplegic Research, Nottwil
Phase
Observational
Overall status
Completed
Start date
November 30, 2013
Completion date
November 30, 2015
Enrollment
47 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neurogenic detrusor overactivity, neurogenic lower urinary tract dysfunction, spinal cord injury